Viatris Inc (VTRS): Free Cash Flow
$1.94B
Year ended 2025-12-31
$1.95B
Trailing 12 months to 2026-06-30
-9.3%
3-year compound annual growth
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.94B | -2.0% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $1.98B | -21.6% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $2.52B | -2.7% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $2.59B | n/c | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $2.56B | +158.9% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $988.80M | -37.8% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $1.59B | -23.9% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $2.09B | n/a | 2021-03-01, From 2018-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Viatris Inc (VTRS) | 2025-12-31 | $1.94B | -2.0% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $4.08B | +11.3% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $3.19B | n/m |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $1.15B | +53.3% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $1.00B | -20.4% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $2.28B | -0.7% |
| Organon & Co. (OGN) | 2025-12-31 | $538.00M | -29.6% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $941.74M | n/m |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $284.00M | -27.9% |
Compare VTRS, REGN, VRTX, TEVA side by side · Screen every company in Pharmaceutical Preparations ↗